GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the effector-immunity protein complex

Analyse Crystal structure of the effector-immunity protein complex in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4NSO
Type
protein
Length
291 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Effector protein; Immunity protein
UniProt
Q9KN42, Q9KN41
Pockets
2 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 67% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEffector proteinprotein19761% helix, 4% strandQ9KN42
BImmunity proteinprotein9479% helix, 0% strandQ9KN41

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12720.690.8444empty
2640.330.7616empty

Interfaces

1 interface between chains.

  • A–B · 1219 Ų buried · 17 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 modified (engineered).

Compared structures

  • 4NSO · Crystal structure of the effector-immunity protein complex · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9KN41 · AlphaFold monomer V2.0 prediction for antitoxin protein TSIV3 (Q9KN41) · a predicted model of the same protein · chain B against A, TM-score 0.94
  • Q9KN42 · AlphaFold monomer V2.0 prediction for type VI secretion system spike protein VGRG3… · a predicted model of the same protein · chain A against A, TM-score 0.90

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.